dc.contributor.author | Sarin, Heikki V. | |
dc.contributor.author | Hulmi, Juha J. | |
dc.contributor.author | Qin, Youwen | |
dc.contributor.author | Inouye, Michael | |
dc.contributor.author | Ritchie, Scott C. | |
dc.contributor.author | Cheng, Susan | |
dc.contributor.author | Watrous, Jeramie D. | |
dc.contributor.author | Nguyen, Thien-Tu C. | |
dc.contributor.author | Lee, Joseph H. | |
dc.contributor.author | Jin, Zhezhen | |
dc.contributor.author | Terwilliger, Joseph D. | |
dc.contributor.author | Niiranen, Teemu | |
dc.contributor.author | Havulinna, Aki | |
dc.contributor.author | Salomaa, Veikko | |
dc.contributor.author | Pietiläinen, Kirsi H. | |
dc.contributor.author | Isola, Ville | |
dc.contributor.author | Ahtiainen, Juha P. | |
dc.contributor.author | Häkkinen, Keijo | |
dc.contributor.author | Jain, Mohit | |
dc.contributor.author | Perola, Markus | |
dc.date.accessioned | 2022-10-11T07:40:15Z | |
dc.date.available | 2022-10-11T07:40:15Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Sarin, H. V., Hulmi, J. J., Qin, Y., Inouye, M., Ritchie, S. C., Cheng, S., Watrous, J. D., Nguyen, T.-T. C., Lee, J. H., Jin, Z., Terwilliger, J. D., Niiranen, T., Havulinna, A., Salomaa, V., Pietiläinen, K. H., Isola, V., Ahtiainen, J. P., Häkkinen, K., Jain, M., & Perola, M. (2022). Substantial Fat Loss in Physique Competitors Is Characterized by Increased Levels of Bile Acids, Very-Long Chain Fatty Acids, and Oxylipins. <i>Metabolites</i>, <i>12</i>(10), Article 928. <a href="https://doi.org/10.3390/metabo12100928" target="_blank">https://doi.org/10.3390/metabo12100928</a> | |
dc.identifier.other | CONVID_157013953 | |
dc.identifier.uri | https://jyx.jyu.fi/handle/123456789/83513 | |
dc.description.abstract | Weight loss and increased physical activity may promote beneficial modulation of the metabolome, but limited evidence exists about how very low-level weight loss affects the metabolome in previously non-obese active individuals. Following a weight loss period (21.1 ± 3.1 weeks) leading to substantial fat mass loss of 52% (−7.9 ± 1.5 kg) and low body fat (12.7 ± 4.1%), the liquid chromatography-mass spectrometry-based metabolic signature of 24 previously young, healthy, and normal weight female physique athletes was investigated. We observed uniform increases (FDR < 0.05) in bile acids, very-long-chain free fatty acids (FFA), and oxylipins, together with reductions in unsaturated FFAs after weight loss. These widespread changes, especially in the bile acid profile, were most strongly explained (FDR < 0.05) by changes in android (visceral) fat mass. The reported changes did not persist, as all of them were reversed after the subsequent voluntary weight regain period (18.4 ± 2.9 weeks) and were unchanged in non-dieting controls (n = 16). Overall, we suggest that the reported changes in FFA, bile acid, and oxylipin profiles reflect metabolic adaptation to very low levels of fat mass after prolonged periods of intense exercise and low-energy availability. However, the effects of the aforementioned metabolome subclass alteration on metabolic homeostasis remain controversial, and more studies are warranted to unravel the complex physiology and potentially associated health implications. In the end, our study reinforced the view that transient weight loss seems to have little to no long-lasting molecular and physiological effects. | en |
dc.format.mimetype | application/pdf | |
dc.language.iso | eng | |
dc.publisher | MDPI | |
dc.relation.ispartofseries | Metabolites | |
dc.rights | CC BY 4.0 | |
dc.subject.other | weight loss | |
dc.subject.other | exercise | |
dc.subject.other | visceral fat mass | |
dc.subject.other | LC-MS metabolome | |
dc.subject.other | bioactive metabolites | |
dc.title | Substantial Fat Loss in Physique Competitors Is Characterized by Increased Levels of Bile Acids, Very-Long Chain Fatty Acids, and Oxylipins | |
dc.type | article | |
dc.identifier.urn | URN:NBN:fi:jyu-202210114839 | |
dc.contributor.laitos | Liikuntatieteellinen tiedekunta | fi |
dc.contributor.laitos | Faculty of Sport and Health Sciences | en |
dc.contributor.oppiaine | Biomekaniikka | fi |
dc.contributor.oppiaine | Valmennus- ja testausoppi | fi |
dc.contributor.oppiaine | Liikuntafysiologia | fi |
dc.contributor.oppiaine | Biomechanics | en |
dc.contributor.oppiaine | Science of Sport Coaching and Fitness Testing | en |
dc.contributor.oppiaine | Exercise Physiology | en |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | |
dc.description.reviewstatus | peerReviewed | |
dc.relation.issn | 2218-1989 | |
dc.relation.numberinseries | 10 | |
dc.relation.volume | 12 | |
dc.type.version | publishedVersion | |
dc.rights.copyright | © 2022 by the authors. Licensee MDPI, Basel, Switzerland. | |
dc.rights.accesslevel | openAccess | fi |
dc.relation.grantnumber | 275922 | |
dc.subject.yso | liikunta | |
dc.subject.yso | fyysinen aktiivisuus | |
dc.subject.yso | painonhallinta | |
dc.subject.yso | kuntoliikunta | |
dc.subject.yso | aineenvaihdunta | |
dc.subject.yso | laihdutus | |
dc.format.content | fulltext | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p916 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p23102 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p822 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p3708 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p3066 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p825 | |
dc.rights.url | https://creativecommons.org/licenses/by/4.0/ | |
dc.relation.doi | 10.3390/metabo12100928 | |
dc.relation.funder | Research Council of Finland | en |
dc.relation.funder | Suomen Akatemia | fi |
jyx.fundingprogram | Academy Research Fellow, AoF | en |
jyx.fundingprogram | Akatemiatutkija, SA | fi |
jyx.fundinginformation | This study was supported by grants from the Finnish Foundation for Cardiovascular Research (M.P. and V.S.), The Finnish Medical Foundation (H.V.S.), and the US National Institutes of Health (K01DK116917 to J.D.W.; S10OD020025, R01ES027595 to M.J.; R01HL143227 to S.C.R.) and by the Academy of Finland (269517 [M.P.]; 275922 [J.J.H.]). K.H.P. was funded by the Academy of Finland, grant numbers 335443, 314383, 272376, 266286; Finnish Medical Foundation; Gyllenberg Foundation; Novo Nordisk Foundation, grant numbers NNF20OC0060547, NNF17OC0027232, NNF10OC1013354; Finnish Diabetes Research Foundation; University of Helsinki and Helsinki University Hospital Government Research Funds. S.C.R. was funded by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (BRC-1215-20014). A.H. was supported by the Academy of Finland, grant #321356. | |
dc.type.okm | A1 | |